Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Saturn V Capital Management LP
Form 13F · Q2 2026

Saturn V Capital Management LP

CIK 1964437Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$697M
Reported book value
23
Positions
12
Quarters on record
Top 50
Positions

Saturn V Capital Management LP — holdings

Top 23 positions of 23, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1AMLX Amylyx Pharmaceuticals Inc4.6M+6.3%$83M11.9%
2ALMS Alumis Inc2.9M−9.0%$82M11.8%
3ABIVAX SA Abivax Sa518,865−4.4%$69M9.9%
4PCVX Vaxcyte Inc852,914+3.4%$50M7.1%
5IMMX Immix Biopharma Inc4.7M+26.1%$48M6.9%
6PHVS Pharvaris N V1.3M+9.4%$45M6.5%
7JAZZ Jazz Pharmaceuticals Plc160,938−1.2%$39M5.6%
8CELC Celcuity Inc370,318+31.4%$39M5.6%
9IRON Disc Medicine Inc524,730+16.6%$38M5.5%
10CADL Candel Therapeutics Inc3.3M+14.1%$34M4.9%
11XFOR X4 Pharmaceuticals Inc7.0M+8.0%$33M4.7%
12MNPR Monopar Therapeutics Inc311,976−9.7%$29M4.1%
13DYN Dyne Therapeutics Inc1.1M+9.4%$23M3.4%
14TRVI Trevi Therapeutics Inc1.1M—$20M2.8%
15ZURA Zura Bio Ltd2.1M+184.0%$12M1.8%
16SGMT Sagimet Biosciences Inc1.5M—$11M1.6%
17OCS Oculis Holding Ag684,880+32.5%$9M1.4%
18IKT Inhibikase Therapeutics Inc3.9M+0.1%$8M1.1%
19VIR Vir Biotechnology Inc770,643—$8M1.1%
20IVVD Invivyd Inc8.4M−23.4%$7M1.0%
21ANRO Alto Neuroscience Inc182,829+105.4%$5M0.7%
22MSLE Satellos Bioscience Inc350,000+0.0%$3M0.4%
23OVID Ovid Therapeutics Inc663,060−84.1%$2M0.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.